Here are relevant reports on : long-term-care-pharmacy-market
-
Veterinary Care Market Size by Treatment Type (No medicalization, Basic Medicalization, and Under Long Term Veterinary Care), Animal Type (Dogs, Cats, Cattle, Horses, Pigs, and Poultry), and Region - Global Forecast to 2025
The global veterinary care market growth is primed to transition from USD 5.2 billion in 2018 to USD 23 billion by 2025, showcasing a strong CAGR of 5.7%. Key factors driving growth include increasing regulatory initiatives and rising demand for animal health products, particularly in regions like Asia and Latin America.
- Published: September 2020
- Price: $ 12000
- TOC Available:
-
Clinical Workflow Solutions Market by Product (Data Integration, Nurse Call Systems, Rounding Solutions, Patient Flow Management, Enterprise Reporting), End Users (Hospitals, Long-term Care, Ambulatory Care Centers) & Region - Global Forecast to 2025
The global clinical workflow solutions market growth is primed to transition from USD 9.1 billion in 2020 to USD 18.1 billion by 2025, showcasing a strong CAGR of 14.8%. Growth in this market is driven by the implementation of government initiatives supporting the adoption of HCIT solutions, advantages of clinical workflow solutions in enhancing patient care and safety, increasing patient volume due to the COVID-19 pandemic, growing adoption of EHRs and other HCIT solutions, and the rising need to curtail healthcare costs.
- Published: August 2020
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Europe Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics, Synbiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Disease), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Europe Human Microbiome Market, valued at US$0.22 billion in 2024, stood at US$0.29 billion in 2025 and is projected to advance at a resilient CAGR of 28.6% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. The growth of the Europe human microbiome market is driven by increased awareness of personalized health, the adoption of microbiome-based therapies, and advancements in sequencing technologies and bioinformatics.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
The Asia Pacific Human Microbiome Market, valued at US$0.19 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. Market growth is driven by an increasing focus on preventive and personalized health, rising adoption of microbiome-based diagnostics and therapeutic solutions, and rapid advances in next-generation sequencing, AI-enabled microbiome analytics, and regional bioinformatics capabilities.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities) and Region - Global Forecasts to 2027
The global infection surveillance solutions market growth is primed to transition from $577 million in 2022 to $1,100 billion by 2027, showcasing a strong CAGR of 13.8%. The market growth is primarily driven by the rising number of hospital-acquired infections (HAIs) and new Medicare policies that include non-payment for hospital-acquired conditions.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Automated blood Tube Labeler & Specimen Transport Box Market – By End User (Hospitals, Diagnostic Center, Skilled Nursing Facility, Long Term Acute Care Facilities), Specimen Transport Box Type (Traditional Boxes, Smart Transportation Boxes) & Geography
The automated blood tube labeler market is projected to grow at a CAGR of 6.8% during the forecast period. The market is dominated by players such as Techno Medica (Japan), Kobayashi Create (Japan), and Inpeco (Switzerland). The major players in specimen transport box market include Sonoco Product Company (US), Greiner Holding (Austria), and Alifax Holdings (Italy).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Long Term Evolution (LTE) Market (2010-2015) By Infrastructure (E-Utran, E Node B, EPC), End-User Devices (Smartphones, USB Modems, Card Modules, Netbooks) & Services
The need for mobile broadband is growing everyday as digital lifestyle continues to evolve with the line between cell phones, mobile handheld devices, PCs and laptops getting blurred. Users continue to show increasing interest for real time applications that include video-conferencing, publishing and social networking. Subscriber’s interest in accessing high bandwidth applications such as YouTube from their mobile phones are further taxing the already stressed networks of mobile service providers. To meet this increasing demand for bandwidth, operators are migrating to LTE, which provides them with an opportunity to introduce new services such as data download, accessing internet from mobiles and ultimately helping them to improve their bottom-line.
- Published: May 2011
- Price: $ 4950
- TOC Available:
-
Patient Handling Equipment Market by Type (Patient Transfer (Ceiling Lifts, Stair Lifts, Slings), Medical Beds, Mobility Equipment (Walkers, Canes, Crutches), Stretchers), Application (Bariatric, Acute, Long-term), End User - Global Forecast to 2030
The global patient handling equipment market, valued at US$11.8 billion in 2024, stood at US$12.4 billion in 2025 and is projected to advance at a resilient CAGR of 5.8% from 2025 to 2030, culminating in a forecasted valuation of US$16.4 billion by the end of the period. The patient handling equipment market is experiencing steady growth, primarily driven by the increasing prevalence of chronic diseases such as neurological disorders & cardiovascular conditions.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
